Back to Journals » OncoTargets and Therapy » Volume 7

Original Research

Brentuximab vedotin for relapsed or refractory CD30+ Hodgkin lymphoma: a multicenter analysis from Asia

       
Total article views   HTML views PDF downloads Totals
13,728 Dovepress* 12,823+ 1,537 14,360
PubMed Central* 905 415 1,320
Totals 13,728 1,952 15,680
*Since 26 September 2014
+Since July 2016

View citations on PubMed and Google Scholar